Cardiovascular Toxicities of Ibrutinib: A Pharmacovigilance Study Based on the United States Food and Drug Administration Adverse Event Reporting System Database is a research paper published in Pharmaceuticals (2023). On theSindex it has a DataRank of 0.373. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.373
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Nature Science Foundation of China
Grant: No. 82073671
National Nature Science Foundation of China
Grant: GWV-10.2-YQ33
National Nature Science Foundation of China
Grant: 03
National Nature Science Foundation of China
Grant: CPA-CDCER-2021-001
Big Data and Artificial Intelligence Application，and Military Key Discipline Construction Project (Health Service-Naval Health Service Organization and Command)
Grant: No.03
the Leading Talents of Public Health in Shanghai
Grant: No. GWV-10.2-XD22
three-year Action Program of Shanghai Municipality for Strengthening the Construction of Public Health System
Grant: GWV-10.1-XK05
the Excellent Young Scholars of public health in Shanghai
Grant: No. GWV-10.2-YQ33
FWCI
1.84
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals